ArticleDiscover nano2025
Automatic design and optimization of MRI-based neurochemical sensors via reinforcement learning.
Article in Discover nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hype vs. Health: How Approved Nanomedicines Have Met (or Missed) Early Predictions.Nanomaterials (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Magnetic resonance imaging (MRI) is a cornerstone of medical imaging, celebrated for its non-invasiveness, high spatial and temporal resolution, and exceptional soft tissue contrast, with over 100 million clinical procedures performed annually worldwide. In this field, MRI-based nanosensors have garnered significant interest in biomedical research due to their tunable sensing mechanisms, high permeability, rapid kinetics, and surface functionality. Extensive studies in the field have reported the use of superparamagnetic iron oxide nanoparticles (SPIONs) and proteins as a proof-of-concept for sensing critical neurochemicals via MRI. However, the signal change ratio and response rate of our SPION-protein-based in vitro dopamine and in vivo calcium sensors need to be further enhanced to detect the subtle and transient fluctuations in neurochemical levels associated with neural activities, starting from in vitro diagnostics. In this paper, we present an advanced reinforcement-learning-based computational model that treats sensor design as an optimal decision-making problem by choosing sensor performance as a weighted reward objective function. The adjustments of the SPION's and protein's three-dimensional configuration and magnetic moment establish a set of actions that can autonomously maximize the cumulative reward in the computational environment. Our new model first elucidates the sensor's conformation alteration behind the increment in T
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.